These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 15655207

  • 1. Risk factors for estrogen receptor-positive breast cancer.
    Hwang ES, Chew T, Shiboski S, Farren G, Benz CC, Wrensch M.
    Arch Surg; 2005 Jan; 140(1):58-62. PubMed ID: 15655207
    [Abstract] [Full Text] [Related]

  • 2. Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma.
    Chen WY, Hankinson SE, Schnitt SJ, Rosner BA, Holmes MD, Colditz GA.
    Cancer; 2004 Oct 01; 101(7):1490-500. PubMed ID: 15378477
    [Abstract] [Full Text] [Related]

  • 3. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
    Chlebowski RT, Anderson GL, Lane DS, Aragaki AK, Rohan T, Yasmeen S, Sarto G, Rosenberg CA, Hubbell FA, Women's Health Initiative Investigators.
    J Natl Cancer Inst; 2007 Nov 21; 99(22):1695-705. PubMed ID: 18000216
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Geographic excess of estrogen receptor-positive breast cancer.
    Benz CC, Clarke CA, Moore DH.
    Cancer Epidemiol Biomarkers Prev; 2003 Dec 21; 12(12):1523-7. PubMed ID: 14693747
    [Abstract] [Full Text] [Related]

  • 6. Risk factors for hormone receptor-defined breast cancer in postmenopausal women.
    Rosenberg LU, Einarsdóttir K, Friman EI, Wedrén S, Dickman PW, Hall P, Magnusson C.
    Cancer Epidemiol Biomarkers Prev; 2006 Dec 21; 15(12):2482-8. PubMed ID: 17164374
    [Abstract] [Full Text] [Related]

  • 7. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
    Basu S, Chen W, Tchou J, Mavi A, Cermik T, Czerniecki B, Schnall M, Alavi A.
    Cancer; 2008 Mar 01; 112(5):995-1000. PubMed ID: 18098228
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Selective reduction of estrogen receptor (ER) positive breast cancer occurrence by estrogen receptor modulators supports etiological distinction between ER positive and ER negative breast cancers.
    Kurbel S.
    Med Hypotheses; 2005 Mar 01; 64(6):1182-7. PubMed ID: 15823713
    [Abstract] [Full Text] [Related]

  • 10. Hormone therapy and breast cancer: what factors modify the association?
    Gertig DM, Fletcher AS, English DR, Macinnis RJ, Hopper JL, Giles GG.
    Menopause; 2006 Mar 01; 13(2):178-84. PubMed ID: 16645531
    [Abstract] [Full Text] [Related]

  • 11. Recreational physical activity and risk of postmenopausal breast cancer based on hormone receptor status.
    Bardia A, Hartmann LC, Vachon CM, Vierkant RA, Wang AH, Olson JE, Sellers TA, Cerhan JR.
    Arch Intern Med; 2006 Mar 01; 166(22):2478-83. PubMed ID: 17159013
    [Abstract] [Full Text] [Related]

  • 12. Reproductive factors, hormone use, estrogen receptor expression and risk of non small-cell lung cancer in women.
    Schwartz AG, Wenzlaff AS, Prysak GM, Murphy V, Cote ML, Brooks SC, Skafar DF, Lonardo F.
    J Clin Oncol; 2007 Dec 20; 25(36):5785-92. PubMed ID: 18089876
    [Abstract] [Full Text] [Related]

  • 13. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
    Pentheroudakis G, Kalogeras KT, Wirtz RM, Grimani I, Zografos G, Gogas H, Stropp U, Pectasides D, Skarlos D, Hennig G, Samantas E, Bafaloukos D, Papakostas P, Kalofonos HP, Pavlidis N, Fountzilas G.
    Breast Cancer Res Treat; 2009 Jul 20; 116(1):131-43. PubMed ID: 18668363
    [Abstract] [Full Text] [Related]

  • 14. Human epidermal growth factor receptor 2 status correlates with lymph node involvement in patients with estrogen receptor (ER) negative, but with grade in those with ER-positive early-stage breast cancer suitable for cytotoxic chemotherapy.
    Bartlett JM, Ellis IO, Dowsett M, Mallon EA, Cameron DA, Johnston S, Hall E, A'Hern R, Peckitt C, Bliss JM, Johnson L, Barrett-Lee P, Ellis P.
    J Clin Oncol; 2007 Oct 01; 25(28):4423-30. PubMed ID: 17906205
    [Abstract] [Full Text] [Related]

  • 15. Unopposed estrogen therapy and the risk of invasive breast cancer.
    Chen WY, Manson JE, Hankinson SE, Rosner B, Holmes MD, Willett WC, Colditz GA.
    Arch Intern Med; 2006 May 08; 166(9):1027-32. PubMed ID: 16682578
    [Abstract] [Full Text] [Related]

  • 16. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
    Mariotto AB, Feuer EJ, Harlan LC, Abrams J.
    J Natl Cancer Inst Monogr; 2006 May 08; (36):7-15. PubMed ID: 17032888
    [Abstract] [Full Text] [Related]

  • 17. Sex hormones, risk factors, and risk of estrogen receptor-positive breast cancer in older women: a long-term prospective study.
    Cummings SR, Lee JS, Lui LY, Stone K, Ljung BM, Cauleys JA.
    Cancer Epidemiol Biomarkers Prev; 2005 May 08; 14(5):1047-51. PubMed ID: 15894651
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Alcohol consumption and breast cancer risk in the Women's Health Study.
    Zhang SM, Lee IM, Manson JE, Cook NR, Willett WC, Buring JE.
    Am J Epidemiol; 2007 Mar 15; 165(6):667-76. PubMed ID: 17204515
    [Abstract] [Full Text] [Related]

  • 20. Determination of threshold values for determining the size of the fraction of steroid hormone receptor-positive tumor cells in paraffin-embedded breast carcinomas.
    Leers MP, Hoop JG, van Beers M, van Rodijnen N, Pannebakker M, Nap M.
    Cytometry B Clin Cytom; 2005 Mar 15; 64(1):43-52. PubMed ID: 15668953
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.